medicaid tirzepatide Does Cover Ozempic, Wegovy, and Other GLP-1 Medications? How Many People Are on

CDA Benchmarks Mounjaro to Ozempic's $228 List Price in Canada Canada's Drug Agency has anchored its draft public-coverage recommendation for Mounjaro to the current list price of Ozempic, suggesting public plans pay no more for 5 mg tirzepatide than they pay for 1 mg semaglutide, currently listed at about $228 per four-week supply [Source: theglobeandmail.com/business/economy/article-canada-drug-agency-mounjaro-recommendation-type-2-diabetes/]

Adherence Barriers Even after overcoming access barriers and obtaining the medication, many patients struggle with adherence

Efficacy of Internet-Based Cognitive Behavioral Therapy for Treatment-Induced Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial

doi:10.1093/cvr/cvaa123 28

Approximately a third of all of patients report experiencing drowsiness while using Mounjaro, indicating that a sizable minority notice meaningful changes in energy levels